Effective Ponatinib 45mg Tablet for CML and Ph+ ALL treatment

The drug can treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The Ponatinib 45mg Tablet works by blocking abnormal BCR-ABL protein that helps in signalling cancer cells to grow and multiply inside the body. This action can also stop the cancer progression and cancer cells which have spread throughout.